Treatment of severe multiple sclerosis (MS) with high-dose immunosuppressive therapy (HDIT) and autologous stem cell transplantation (SCT): 2 year follow-up.


Conference Paper

Full Text

Duke Authors

Cited Authors

  • Nash, RA; Bowen, JD; McSweeney, PA; Sullivan, KM; Pavletic, ZS; Maravilla, KR; Al-Omaishi, J; Corboy, JR; Derrington, D; DiPersio, J; Georges, GE; Gooley, T; Holmberg, LA; LeMaistre, CF; Openshaw, H; Ryan, K; Sunderhaus, J; Storek, J; Zunt, J; Storb, R; Kraft, GH

Published Date

  • November 16, 2002

Published In

Volume / Issue

  • 100 / 11

Start / End Page

  • 864A - 864A

Published By


  • 1

International Standard Serial Number (ISSN)

  • 0006-4971

Conference Name

  • 44th Annual Meeting of the American-Society-of-Hematology

Conference Location


Conference Start Date

  • December 6, 2002

Conference End Date

  • December 10, 2002